Publications
Publications
- April 2006 (Revised May 2009)
- HBS Case Collection
Inverness Medical Innovations - Born Global (A)
Abstract
Ron Zwanziger has just started his third company, having just sold the last one for $1.3 billion to Johnson & Johnson. As part of the deal with J&J, certain assets were transferred to the new company, Inverness Medical Innovations, which, at the time of its creation, had $24 million in half-year sales, $40 million on its balance sheet, and worldwide operations. How were Zwanziger and his team going to transform these disparate assets into a company worth $7 billion in the coming seven years?
Keywords
Globalized Firms and Management; Mergers and Acquisitions; Entrepreneurship; Health Care and Treatment; Corporate Finance; Medical Devices and Supplies Industry; Health Industry; Waltham
Citation
Isenberg, Daniel J. "Inverness Medical Innovations - Born Global (A)." Harvard Business School Case 806-177, April 2006. (Revised May 2009.)